These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 17100674)

  • 21. Intravenous and oral amiodarone for the prevention of postoperative atrial fibrillation in patients undergoing off-pump coronary artery bypass surgery.
    Turk T; Ata Y; Vural H; Ozkan H; Yavuz S; Ozyazicioglu A
    Heart Surg Forum; 2007; 10(4):E299-303. PubMed ID: 17599879
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical Pharmacology-Driven Translational Research to Optimize Bedside Therapeutics of Sotalol Therapy.
    Dahmane E; Tang K; Gobburu JVS; Mattingly TJ; Reed BN; See VY; Ayres J; Ivaturi V
    Clin Transl Sci; 2019 Nov; 12(6):648-656. PubMed ID: 31328888
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Electrocardiographic markers of repolarization heterogeneity during dofetilide or sotalol initiation for paroxysmal atrial fibrillation.
    Sauer AJ; Kaplan R; Xue J; Dorsey P; Hayes M; Shah SJ; Passman R
    Am J Cardiol; 2014 Jun; 113(12):2030-5. PubMed ID: 24793679
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sotalol: a new class III antiarrhythmic agent.
    Zanetti LA
    Clin Pharm; 1993 Dec; 12(12):883-91. PubMed ID: 8137605
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sustained torsade de pointes occurring early during oral sotalol therapy for atrial fibrillation recurrence prophylaxis in a patient without heart disease.
    D'Aloia A; Faggiano P; Brentana L; Boldini A; Pedrinazzi C; Procopio R; Dei Cas L
    Int J Cardiol; 2005 Dec; 105(3):337-9. PubMed ID: 15985302
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of intrapericardial sotalol and flecainide on transmural atrial electrophysiology and atrial fibrillation.
    van Brakel TJ; Hermans JJ; Accord RE; Schotten U; Smits JF; Allessie MA; Maessen JG
    J Cardiovasc Electrophysiol; 2009 Feb; 20(2):207-15. PubMed ID: 19175851
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessment of Sotalol and Dofetilide Dosing at a Large Academic Medical Center.
    Ting C; Malloy R; Knowles D
    J Cardiovasc Pharmacol Ther; 2020 Sep; 25(5):438-443. PubMed ID: 32347108
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The efficacy and safety of apixaban, an oral, direct factor Xa inhibitor, as thromboprophylaxis in patients following total knee replacement.
    Lassen MR; Davidson BL; Gallus A; Pineo G; Ansell J; Deitchman D
    J Thromb Haemost; 2007 Dec; 5(12):2368-75. PubMed ID: 17868430
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Concurrent supplement of estradiol and progesterone reduces the cardiac sensitivity to D,L-sotalol-induced arrhythmias in ovariectomized rabbits.
    Cheng J; Su D; Ma X; Li H
    J Cardiovasc Pharmacol Ther; 2012 Jun; 17(2):208-14. PubMed ID: 21875897
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development of a safe and effective pediatric dosing regimen for sotalol based on population pharmacokinetics and pharmacodynamics in children with supraventricular tachycardia.
    Läer S; Elshoff JP; Meibohm B; Weil J; Mir TS; Zhang W; Hulpke-Wette M
    J Am Coll Cardiol; 2005 Oct; 46(7):1322-30. PubMed ID: 16198851
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A randomized trial of circumferential pulmonary vein ablation versus antiarrhythmic drug therapy in paroxysmal atrial fibrillation: the APAF Study.
    Pappone C; Augello G; Sala S; Gugliotta F; Vicedomini G; Gulletta S; Paglino G; Mazzone P; Sora N; Greiss I; Santagostino A; LiVolsi L; Pappone N; Radinovic A; Manguso F; Santinelli V
    J Am Coll Cardiol; 2006 Dec; 48(11):2340-7. PubMed ID: 17161267
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevention of atrial fibrillation with moderate doses of amiodarone in the postoperative period of cardiac surgery is safe and effective in patients with high risk for developing this arrhythmia.
    Alves RJ; Geovanini GR; Brito Gd; Miguel GA; Glauser VA; Nakiri K
    Arq Bras Cardiol; 2007 Jul; 89(1):22-7. PubMed ID: 17768579
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acute beta-adrenoceptor blockade improves efficacy of ibutilide in conversion of atrial fibrillation with a rapid ventricular rate.
    Fragakis N; Bikias A; Delithanasis I; Konstantinidou M; Liakopoulos N; Kozirakis M; Katsaris G
    Europace; 2009 Jan; 11(1):70-4. PubMed ID: 18987127
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetics and pharmacodynamics of sotalol in a pediatric population with supraventricular and ventricular tachyarrhythmia.
    Saul JP; Ross B; Schaffer MS; Beerman L; Melikian AP; Shi J; Williams J; Barbey JT; Jin J; Hinderling PH;
    Clin Pharmacol Ther; 2001 Mar; 69(3):145-57. PubMed ID: 11240979
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A randomized trial evaluating amiodarone for prevention of atrial fibrillation after pulmonary resection.
    Tisdale JE; Wroblewski HA; Wall DS; Rieger KM; Hammoud ZT; Young JV; Kesler KA
    Ann Thorac Surg; 2009 Sep; 88(3):886-93; discussion 894-5. PubMed ID: 19699916
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cost of hospital admission for antiarrhythmic drug initiation in atrial fibrillation.
    Kim MH; Klingman D; Lin J; Pathak P; Battleman DS
    Ann Pharmacother; 2009 May; 43(5):840-8. PubMed ID: 19417111
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Does prophylactic sotalol and magnesium decrease the incidence of atrial fibrillation following coronary artery bypass surgery: a propensity-matched analysis.
    Aerra V; Kuduvalli M; Moloto AN; Srinivasan AK; Grayson AD; Fabri BM; Oo AY
    J Cardiothorac Surg; 2006 Mar; 1():6. PubMed ID: 16722587
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevention of life-threatening ventricular tachyarrhythmia by a novel and pure class-III agent, nifekalant hydrochloride.
    Ohashi J; Yasuda S; Miyazaki S; Shimizu W; Morii I; Kurita T; Kawamura A; Kamakura S; Nonogi H
    J Cardiovasc Pharmacol; 2006 Dec; 48(6):274-9. PubMed ID: 17204905
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of levalbuterol and racemic albuterol in hospitalized patients with acute asthma or COPD: a 2-week, multicenter, randomized, open-label study.
    Donohue JF; Hanania NA; Ciubotaru RL; Noe L; Pasta DJ; Schaefer K; Claus R; Andrews WT; Roach J
    Clin Ther; 2008; 30 Spec No():989-1002. PubMed ID: 18640474
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transdermal buprenorphine patches applied in a 4-day regimen versus a 3-day regimen: a single-site, Phase III, randomized, open-label, crossover comparison.
    Likar R; Lorenz V; Korak-Leiter M; Kager I; Sittl R
    Clin Ther; 2007 Aug; 29(8):1591-606. PubMed ID: 17919542
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.